Form 4 for CAI Caris Life Sciences, Inc.
Accepted 2026-05-18 16:23:02 ET · period of report 2026-05-15 · accession 0002071959-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 16:23 | 2026-05-15 | CAI | Brille Brian J | See Remarks, Dir | F - Tax | $15.25 | -14.0K | 230.3K | -6% | -$213.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | F | D | 13,987 | $15.25 | 230,303 | D | — | — | (F1) Shares withheld for the payment of taxes on the vesting and settlement of RSUs. |